This inventor holds 38 USPTO granted patents and 54 published patent applications, plus 8 CIPO patents and 10 EPO patents, primarily in Pharmaceutical Formulations. Top assignees: Cumberland Pharmaceuticals, Inc., Vanderbilt University, Oncolytics Biotech Inc.. Active years: 2004-2024.
Location History:
- Morrisville, NC (US) (2004 - 2013)
- Cary, NC (US) (2012 - 2023)
Company Filing History:
31 out of 32 
8 out of 1,220 
4 out of 65 
Years Active: 2004-2024
Areas of Expertise:
Title: Unveiling the Innovations of Leo Pavliv: A Pioneer in Pharmaceutical Patents
Introduction:
Leo Pavliv, a distinguished inventor based in Cary, NC (US), has made significant contributions to the field of pharmaceuticals, holding an impressive portfolio of 37 patents. His groundbreaking inventions have revolutionized the realms of pain management and respiratory disease treatment, showcasing his unwavering commitment to innovation and healthcare advancement.
Latest Patents:
1. Injectable Ibuprofen Formulation: Leo Pavliv's latest invention introduces a novel pharmaceutical composition comprising an aqueous solution of an ibuprofen solubilizing agent and ibuprofen. This formulation ensures the solubility of ibuprofen at concentrations ranging from 100 mg/mL to 5 mg/mL without undergoing a phase transition, offering a promising solution for treating pain, inflammation, fever, and patent ductus arteriosus.
2. Thromboxane Receptor Antagonists in AERD/Asthma: Another pioneering invention by Leo Pavliv focuses on the treatment of Aspirin Exacerbated Respiratory Disease (AERD) and asthma through the administration of a thromboxane receptor antagonist. This method represents a significant advancement in managing these respiratory conditions, highlighting Pavliv's expertise in developing innovative therapeutic strategies.
Career Highlights:
Leo Pavliv's exceptional career path includes esteemed tenures at Cumberland Pharmaceuticals, Inc. and Vanderbilt University. His professional journey reflects a deep-rooted passion for scientific research and pharmaceutical development, culminating in a prolific record of patents that have reshaped the landscape of medical treatment.
Collaborations:
Throughout his career, Leo Pavliv has collaborated with esteemed professionals in the field, including notable coworkers such as Amy Dix Rock and Bryan Voss. These collaborations have facilitated the exchange of knowledge, expertise, and ideas, fostering a culture of innovation and collaboration in the realm of pharmaceutical research.
Conclusion:
In conclusion, Leo Pavliv stands as a visionary inventor whose ingenuity and dedication have propelled the pharmaceutical industry forward. His pioneering patents in pain management and respiratory disease treatment exemplify a steadfast commitment to advancing healthcare solutions and improving patient outcomes. Leo Pavliv's legacy as an inventive trailblazer continues to inspire future generations of inventors and researchers in the pursuit of groundbreaking discoveries in the realm of pharmaceutical innovation.